Common use of Permitted Free Writing Prospectuses Clause in Contracts

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 31 contracts

Samples: Underwriting Agreement (Functional Brands Inc.), Underwriting Agreement (SRIVARU Holding LTD), Underwriting Agreement (SRIVARU Holding LTD)

AutoNDA by SimpleDocs

Permitted Free Writing Prospectuses. The Company represents and agrees that it has Ventas Entities shall not made and, unless it obtains the prior consent of the Representative, will not make, make any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 under the Securities Act without the prior written consent of the Rules and RegulationsRepresentatives; provided that the prior written consent of the Representative hereto Representatives shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included identified in Schedule I heretoB hereto and any electronic road show. Any such Issuer Free Writing Prospectus or other free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, Prospectus and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If The Ventas Entities consent to the use by any Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the preliminary terms of the Notes or their offering, (ii) information that describes the final terms of the Notes or their offering and that is included in the Final Term Sheet of the Ventas Entities contemplated in Section 1(iv) hereof, or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Ventas Entities being required to file with the Commission under Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that would not be required to be filed by the Ventas Entities thereunder but for the action of the Underwriter. If, at any time following the issuance of an Issuer Free Writing Prospectus there occurs an Prospectus, any event or development shall occur as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities that has not been superseded or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleadingmodified, the Company will Ventas Entities agree to promptly notify the Representative Representatives of such event and will promptly amend or supplement, at its own expense, supplement such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 21 contracts

Samples: Underwriting Agreement (Ventas, Inc.), Underwriting Agreement (Ventas, Inc.), Underwriting Agreement (Ventas, Inc.)

Permitted Free Writing Prospectuses. (a) The Company represents and agrees that it has not made andthat, unless it obtains without the prior consent of the RepresentativeAgent, it has not made and will not make, make any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of 405; the Rules Agent represents and Regulationsagrees that, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that without the prior written consent of the Representative hereto shall be deemed Company, it has not made and will not make any offer relating to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any Securities that would constitute a free writing prospectus; any such free writing prospectus the use of which has been consented to by the Representative Agent is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including listed in respect of timely filing with the Commission, legending and record keepingExhibit F hereto. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an any event shall occur or development condition shall exist as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement relating to Statement, any preliminary prospectus or the Offered Securities Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing existing at that subsequent time, not misleading, the Company will promptly notify the Representative Placement Agents and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, statement or omission. . (b) The Company has complied and will comply with the requirements of Rule 433 applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission or retention where required and legending; and the Company represents that it has satisfied and agrees that it will satisfy the conditions in under Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 10 contracts

Samples: Equity Distribution Agreement (Dupont Fabros Technology, Inc.), Equity Distribution Agreement (Dupont Fabros Technology, Inc.), Equity Distribution Agreement (Dupont Fabros Technology, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 10 contracts

Samples: Underwriting Agreement (Graphic Packaging Holding Co), Underwriting Agreement (ExamWorks Group, Inc.), Underwriting Agreement (Graphic Packaging Holding Co)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeUnderwriters, will not make, any offer relating to the Offered Securities Units that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Underwriters hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative Underwriters is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If If, at any time following the issuance of an Issuer Free Writing Prospectus Prospectus, there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Units or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Underwriters and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 9 contracts

Samples: Underwriting Agreement (Ocelot Acquisition Corp I), Underwriting Agreement (G&P Acquisition Corp.), Underwriting Agreement (G&P Acquisition Corp.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 9 contracts

Samples: Underwriting Agreement (Achieve Life Sciences, Inc.), Underwriting Agreement (Boxlight Corp), Underwriting Agreement (ImmunoCellular Therapeutics, Ltd.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 6 contracts

Samples: Underwriting Agreement (Gamida Cell Ltd.), Underwriting Agreement (American Resources Corp), Underwriting Agreement (American Resources Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I C hereto. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that it (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating The Company consents to the Offered Securities or would include use by any Underwriter of a free writing prospectus that (a) is not an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions “issuer free writing prospectus” as defined in Rule 433 of the Securities Act, or (b) contains only (1) information describing the preliminary terms of the Securities or their offering or other information included in the Disclosure Package, (2) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Company not to avoid a requirement take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Company being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of such Underwriter.

Appears in 6 contracts

Samples: Underwriting Agreement (Celanese Corp), Underwriting Agreement (Celanese Corp), Underwriting Agreement (Celanese Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 6 contracts

Samples: Underwriting Agreement (Autonation, Inc.), Underwriting Agreement (Autonation, Inc.), Underwriting Agreement (Autonation, Inc.)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 5 contracts

Samples: Equity Distribution Agreement (Uranium Royalty Corp.), Equity Distribution Agreement, Equity Distribution Agreement (GoldMining Inc.)

Permitted Free Writing Prospectuses. The Company Issuer represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by the Issuer with the Commission or retained by the Company Issuer under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included identified in Schedule Annex I heretoand Axxxx XX to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Issuer agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Issuer consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an the Securities or their offering or (ii) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict contemplated in Section 3(k); provided that each Underwriter severally covenants with the information contained Issuer not to take any action without the Issuer’s consent that would result in the Registration Statement relating a free writing prospectus being required to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission any electronic road showunder Rule 433(d) under the Securities Act that otherwise would not be required to be filed by the Issuer thereunder, but for the action of such Underwriter.

Appears in 5 contracts

Samples: Underwriting Agreement (Prologis, L.P.), Underwriting Agreement (Prologis, Inc.), Underwriting Agreement (Prologis, L.P.)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 5 contracts

Samples: Equity Distribution Agreement (First Majestic Silver Corp), Equity Distribution Agreement (First Majestic Silver Corp), Equity Distribution Agreement (First Majestic Silver Corp)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a "Permitted Free Writing Prospectus." The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 4 contracts

Samples: Equity Distribution Agreement (Platinum Group Metals LTD), Equity Distribution Agreement (Platinum Group Metals LTD), Equity Distribution Agreement (Metalla Royalty & Streaming Ltd.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d)(iv) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 4 contracts

Samples: Underwriting Agreement (Comstock Resources Inc), Underwriting Agreement (Comstock Oil & Gas GP, LLC), Underwriting Agreement (Bill Barrett Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Public Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Public Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 4 contracts

Samples: Underwriting Agreement (Chromocell Therapeutics Corp), Underwriting Agreement (Chromocell Therapeutics Corp), Underwriting Agreement (Chromocell Therapeutics Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, Prospectus and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, statement or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 4 contracts

Samples: Underwriting Agreement (Nexalin Technology, Inc.), Underwriting Agreement (Nexalin Technology, Inc.), Underwriting Agreement (Nexalin Technology, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeUnderwriter, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Underwriter hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative Underwriter is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus Prospectus, there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Underwriter and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 4 contracts

Samples: Underwriting Agreement (Medirom Healthcare Technologies Inc.), Underwriting Agreement (Medirom Healthcare Technologies Inc.), Underwriting Agreement (Medirom Healthcare Technologies Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 4 contracts

Samples: Underwriting Agreement (Founder Group LTD), Underwriting Agreement (Founder Group LTD), Underwriting Agreement (La Rosa Holdings Corp.)

Permitted Free Writing Prospectuses. The Company represents Issuers represent that they have not made, and agrees that it has not made andagree that, unless it obtains they obtain the prior written consent of the Representative, they will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Issuers with the Commission or retained by the Company Issuers under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Issuers agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Issuers consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Issuers contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Issuers not to take any action without the Issuers’ consent, which consent shall be confirmed in writing, that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Issuers being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Issuers thereunder, but for the action of the Underwriter.

Appears in 4 contracts

Samples: Underwriting Agreement (Suburban Propane Partners Lp), Underwriting Agreement (Suburban Propane Partners Lp), Underwriting Agreement (Suburban Propane Partners Lp)

Permitted Free Writing Prospectuses. The Company represents and the Guarantor jointly and severally represent, warrant and agree that they have not made and, unless they obtain the prior written consent of the Representatives, will not make, and each Underwriter, severally and not jointly, represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeCompany, the Guarantor and the Representatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 405) or portion thereof required, in the case of any Underwriters, to be filed with the Commission or, in the case of the Rules and RegulationsCompany or the Guarantor, whether or not required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsCommission; provided that the prior written consent of the Representative hereto Company, the Guarantor and the Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit D-1 hereto and to any electronic road show in Schedule I heretothe form previously provided by the Company to and approved by the Representatives. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees and the Guarantor jointly and severally represent, warrant and agree that (i) it has they have treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has have complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at any time following For the issuance purposes of an Issuer clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit D hereto are Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 4 contracts

Samples: Underwriting Agreement (CRH Public LTD Co), Underwriting Agreement (CRH Public LTD Co), Underwriting Agreement (CRH Public LTD Co)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeRepresentatives, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I III hereto. Any such free writing prospectus consented to by the Representative Representatives is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keepingrecordkeeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 3 contracts

Samples: Underwriting Agreement (Kura Sushi Usa, Inc.), Underwriting Agreement (Kura Sushi Usa, Inc.), Underwriting Agreement (Kura Sushi Usa, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeUnderwriter, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Underwriter hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoD hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Underwriter is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included on Schedule D hereto contemplated in Section 1(A)(d) or (3) information permitted under Rule 134 under the Securities Act; provided that the Underwriter covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 3 contracts

Samples: Underwriting Agreement (Graphic Packaging Holding Co), Underwriting Agreement (Graphic Packaging Holding Co), Underwriting Agreement (Graphic Packaging Holding Co)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoD hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included on Schedule D hereto contemplated in Section 1(A)(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 3 contracts

Samples: Underwriting Agreement (Clayton Dubilier & Rice Fund v L P), Underwriting Agreement (Graphic Packaging Holding Co), Underwriting Agreement (Clayton Dubilier & Rice Fund v L P)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses Prospectus included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” ”. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, Prospectus and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating The Company consents to the Offered Securities or would include use by any Underwriter of a free writing prospectus that (a) is not an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions “issuer free writing prospectus” as defined in Rule 433 and (b) contains only (i) information describing the preliminary terms of the Notes or their offering, (ii) information that describes the final terms of the Notes or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 4(d) or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Company not to avoid a requirement take any action without the Company’s consent (which consent shall be confirmed in writing) that would result in the Company being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 3 contracts

Samples: Underwriting Agreement (RR Donnelley & Sons Co), Underwriting Agreement (RR Donnelley & Sons Co), Underwriting Agreement (RR Donnelley & Sons Co)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 3 contracts

Samples: Underwriting Agreement (Activision Blizzard, Inc.), Underwriting Agreement (SM Energy Co), Underwriting Agreement (SM Energy Co)

Permitted Free Writing Prospectuses. The (i) Each of the Company and the Guarantor represents and agrees that it has not made andmade, and unless it obtains the prior written consent (which may be in electronic form) of the Representativeapplicable Selling Agents or their counsel, it will not make, and each Selling Agent represents and agrees that it has not made, and unless it obtains the prior written consent (which may be in electronic form) of the Company and the Guarantor, it will not make, any offer relating to the Offered Securities Notes that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, Securities Act) required to be filed with the Commission or retained by the Company under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Selling Agents shall be deemed to have been given in with respect of the to each Issuer Free Writing Prospectuses included Prospectus (including any Final Term Sheet) approved by such Selling Agents (or their counsel) in Schedule I heretoconnection with an offering of Notes pursuant to this Agreement. Any such free writing prospectus consented to by the Representative Company, the Guarantor and the applicable Selling Agent or Selling Agents (or their counsel) is herein referred to herein as a “Permitted Free Writing Prospectus.” The Unless otherwise agreed by the Company, the Guarantor and the applicable Selling Agents, the Company agrees that and the Guarantor (iA) it has have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (iiB) has have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of the contents thereof, timely filing with the Commission, legending and record keeping. If at Each of the Company and the Guarantor consents to the use by any Selling Agent of a free writing prospectus that (1) is not an “issuer free writing prospectus” as defined in such Rule 433, and (2) complies with the requirements of Rule 164 and Rule 433 and contains only (X) information describing the preliminary terms of the Notes (and related Guarantee) or their offering, (Y) information permitted by Rule 134 under the Securities Act or (Z) information that describes the final terms of the Notes (and related Guarantee) or their offering and that is included in the Final Term Sheet contemplated in Section 4(a) of this Agreement. In addition, a Selling Agent may use and distribute a road show (as defined in such Rule 433) prepared or recorded with the Guarantor, unless (1) the Guarantor reasonably requests otherwise in writing and (2) the Guarantor otherwise ceases its own use or replay of such road show. The prior sentence shall not limit any of the Guarantor’s obligations under paragraph (e) above. (ii) The Company, the Guarantor and each Selling Agent acknowledge that the parties hereto may formulate from time following to time written policies governing free writing prospectuses that vary and differ from the issuance provisions of an Issuer this Section 3(f). Such written policies may be applicable to one or more issuances of Notes, and may relate to, without limitation, (A) the obligations of the Company, the Guarantor and the Selling Agents for filing free writing prospectuses with the Commission, (B) procedures for the preparation, review and use of free writing prospectuses, (C) the Selling Agent’s preparation and distribution of free writing prospectuses that are not subject to the filing requirements of Rule 433(d)(1)(ii) under the Securities Act (a “Selling Agent Represented Limited-Use Free Writing Prospectus there occurs an event or development as Prospectus”), (D) whether the use of any free writing prospectus shall be conditioned upon the delivery of a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating legal opinion from counsel to the Offered Securities Company and the Guarantor and/or the Selling Agents and (E) any other related matters as the Company and the Guarantor may agree from time with one or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light more of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showSelling Agents.

Appears in 3 contracts

Samples: Distribution Agreement (BofA Finance LLC), Distribution Agreement (BofA Finance LLC), Distribution Agreement (Bank of America Corp /De/)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 3 contracts

Samples: Equity Distribution Agreement (NexGen Energy Ltd.), Equity Distribution Agreement (NexGen Energy Ltd.), Equity Distribution Agreement

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectus. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectus or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 3 contracts

Samples: Equity Distribution Agreement (Sandstorm Gold LTD), Equity Distribution Agreement (Sandstorm Gold LTD), Equity Distribution Agreement (Eldorado Gold Corp /Fi)

Permitted Free Writing Prospectuses. The Company Issuer represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by the Issuer with the Commission or retained by the Company Issuer under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included identified in Schedule Annex I heretoand Annex II to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Issuer agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Issuer consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an the Securities or their offering or (ii) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict contemplated in Section 3(k); provided that each Underwriter severally covenants with the information contained Issuer not to take any action without the Issuer’s consent that would result in the Registration Statement relating a free writing prospectus being required to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission any electronic road showunder Rule 433(d) under the Securities Act that otherwise would not be required to be filed by the Issuer thereunder, but for the action of such Underwriter.

Appears in 3 contracts

Samples: Underwriting Agreement (Prologis, L.P.), Underwriting Agreement (Prologis, L.P.), Underwriting Agreement (Prologis, L.P.)

Permitted Free Writing Prospectuses. The Company represents and the Operating Partnership represent, warrant and agree that they have not made and, unless they obtain the prior written consent of the Representatives, will not make, and each Underwriter, severally and not jointly, represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeCompany, the Operating Partnership and the Representatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 405) or portion thereof required, in the case of any Underwriters, to be filed with the Commission or, in the case of the Rules Company and Regulationsthe Operating Partnership, whether or not required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsCommission; provided that the prior written consent of the Representative hereto Company, the Operating Partnership and the Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit F hereto and to any electronic road show in Schedule I heretothe form previously provided by the Company and the Operating Partnership to and approved by the Representatives. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees and the Operating Partnership represent, warrant and agree that (i) it has they have treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at any time following For the issuance purposes of an Issuer clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit F hereto are Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 2 contracts

Samples: Underwriting Agreement (Healthcare Trust of America Holdings, LP), Underwriting Agreement (Healthcare Trust of America Holdings, LP)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has Ventas Entities shall not made and, unless it obtains the prior consent of the Representative, will not make, make any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 under the Securities Act without the prior written consent of the Rules and RegulationsRepresentatives; provided that the prior written consent of the Representative hereto Representatives shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included identified in Schedule I heretoB hereto and any electronic road show. Any such Issuer Free Writing Prospectus or other free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, Prospectus and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If The Ventas Entities consent to the use by any Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the preliminary terms of the Notes or their offering, (ii) information that describes the final terms of the Notes or their offering and that is included in the Final Term Sheet of the Ventas Entities contemplated in Section 1(a)(iv) hereof, or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Ventas Entities being required to file with the Commission under Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that would not be required to be filed by the Ventas Entities thereunder but for the action of the Underwriter. If, at any time following the issuance of an Issuer Free Writing Prospectus there occurs an Prospectus, any event or development shall occur as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities that has not been superseded or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleadingmodified, the Company will Ventas Entities agree to promptly notify the Representative Representatives of such event and will promptly amend or supplement, at its own expense, supplement such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Ventas, Inc.), Underwriting Agreement (Ventas, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities that would constitute a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a "Permitted Free Writing Prospectus." The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Medicus Pharma Ltd.), Underwriting Agreement (Medicus Pharma Ltd.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Autonation, Inc.), Underwriting Agreement (Autonation, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeUnderwriter, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission (and the ASX) or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Underwriter hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative Underwriter is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Underwriter and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Benitec Biopharma LTD/ADR), Underwriting Agreement (Benitec Biopharma LTD/ADR)

Permitted Free Writing Prospectuses. The Company represents Each of the Parent Guarantor and agrees the Issuer represent that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeUnderwriter, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by either the Parent Guarantor or the Issuer with the Commission or retained by either the Company Parent Guarantor or the Issuer under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriter shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included in Schedule Annex I heretoto this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriter is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Each of the Parent Guarantor and the Issuer agrees that it (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following Each of the issuance Parent Guarantor and the Issuer consents to the use by the Underwriter of a free writing prospectus that (a) is not an Issuer Free Writing Prospectus there occurs an event “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the preliminary terms of the Securities or development as a result their offering, (ii) information permitted by Rule 134 under the Securities Act or (iii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict with the information contained Securities or their offering and that is included in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light Final Term Sheet of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions contemplated in Rule 433 to avoid a requirement to file with the Commission any electronic road showSection 3(l).

Appears in 2 contracts

Samples: Underwriting Agreement (Thermo Fisher Scientific Inc.), Underwriting Agreement (Thermo Fisher Scientific Inc.)

Permitted Free Writing Prospectuses. The Company represents Ventas Entities represent, jointly and agrees severally, that it has they have not made andmade, and agree that, unless it obtains they obtain the prior written consent of the RepresentativeRepresentatives, they will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Ventas Entities consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Notes or development as a result their offering, (ii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Notes or their offering and that is included in the Final Term Sheet of the Ventas Entities contemplated in Section 1(iv) hereof, or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Ventas Entities being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Ventas Entities thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Ventas Inc), Underwriting Agreement (Ventas Inc)

Permitted Free Writing Prospectuses. ‎ (i) The Company represents and agrees that it has not made and, unless it obtains ‎obtains the prior written consent of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities that Shares ‎that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations‎Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations‎Regulations; provided that the prior written consent of the Representative Agents hereto shall be deemed to have been ‎been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such ‎such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing ‎Writing Prospectus.” ”. The Company represents and agrees that (i) it has treated and will shall treat, as the ‎the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined ‎in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may ‎may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing ‎Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission‎Commission, legending and record keeping. If at The Company agrees not to take any time following action that ‎would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under ‎the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise ‎would not have been required to file thereunder.‎ (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, ‎will include any information that conflicts with the information contained in the Registration Statement relating to ‎Statement, including any document incorporated by reference therein that has not been ‎superseded or modified, or the Offered Securities or would Prospectus. In addition, no Permitted Free Writing Prospectus, ‎if any, together with the Prospectus, will include an untrue statement of a material fact or would omit to ‎to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing ‎under which they were made, not misleading; provided however, the foregoing shall not apply to ‎any statements or omissions in any Permitted Free Writing Prospectus made in reliance on ‎information furnished in writing to the Company by the Agents expressly stating that such ‎information is intended for use therein.‎ (iii) The Company agrees that if at any time following issuance of an ‎Permitted Free Writing Prospectus any event occurred or occurs as a result of which such ‎Permitted Free Writing Prospectus would conflict with the information in the Registration ‎Statement, including any document incorporated by reference therein that subsequent timehas not been ‎superseded or modified, or the Prospectus or would include an untrue statement of a material ‎fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt ‎notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without ‎charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such ‎such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any ‎statements or omissions in any Permitted Free Writing Prospectus made in reliance on ‎information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.such ‎information is intended for use therein.‎

Appears in 2 contracts

Samples: Equity Distribution Agreement (Dakota Gold Corp.), Equity Distribution Agreement (Dakota Gold Corp.)

Permitted Free Writing Prospectuses. The Company represents represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, 405) or portion thereof required to be filed with the Commission or required to be retained by the Company under pursuant to Rule 433 of the Rules and Regulations433; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit H hereto and, to any electronic road show in Schedule I heretothe form previously provided by the Company to and approved by the Representative. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents, warrants and agrees that (i) it has treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at any time following For the issuance purposes of an Issuer clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit H hereto are Permitted Free Writing Prospectus there occurs an event or development as a result Prospectuses. Each Underwriter represents, warrants and agrees that, without the consent of which such Issuer Free Writing Prospectus would conflict with the information contained in Company and the Registration Statement Representative, it has not made and will not make any offer relating to the Offered Securities or that would include an untrue statement of material fact or constitute a free writing prospectus that would omit be required to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission any electronic road showother than a Permitted Free Writing Prospectus, if any.

Appears in 2 contracts

Samples: Underwriting Agreement (Northwest Natural Holding Co), Underwriting Agreement (Northwest Natural Holding Co)

Permitted Free Writing Prospectuses. The Company represents represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, 405) or portion thereof required to be filed with the Commission or required to be retained by the Company under pursuant to Rule 433 of the Rules and Regulations433; provided that the prior written consent of the Representative hereto Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit F hereto, to any electronic road show in Schedule I the form previously provided by the Company to and approved by the Representatives, and to any Issuer DSP Free Writing Prospectus listed on Exhibit G hereto. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents, warrants and agrees that (i) it has treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at , and the only information included in any time following the issuance of an Issuer DSP Free Writing Prospectus there occurs an event is the same information that is set forth in Exhibit E hereto. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit F or development as a result of which such Issuer Exhibit G hereto are Permitted Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 2 contracts

Samples: Underwriting Agreement (Carvana Co.), Underwriting Agreement (Carvana Co.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeRepresentatives, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative Representatives is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Gamida Cell Ltd.), Underwriting Agreement (Gamida Cell Ltd.)

Permitted Free Writing Prospectuses. (A) The Company represents and warrants to, and agrees that it has not made andwith, the applicable Agent that, unless it obtains the prior consent of the Representativeapplicable Agent prior to the use thereof, it has not made and will not makemake any offer relating to Notes for which that Agent is acting as an agent or which that Agent is purchasing as a principal that would constitute an “issuer free writing prospectus,” as defined in Rule 433 under the Securities Act, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 under the Securities Act, required to be filed with the Commission. (B) Each applicable Agent, severally and not jointly, represents and warrants to, and agrees with, the Company and each other applicable Agent that, unless it obtains the consent of the Company and the other applicable Agents (if any) prior to the use thereof, it has not made and will not make any offer relating to the Offered Securities Notes that would constitute a “free writing prospectus” as defined in Rule 405 of under the Rules and Regulations, Securities Act required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; Commission, provided that the prior written consent of the Representative hereto Company and the other applicable Agents (if any) shall be deemed to have been given in respect of the any Approved Term Sheet or Approved Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative is herein referred to Prospectus attached as a “Permitted Free Writing Prospectusschedule to any applicable Terms Agreement and to communications described in Section 3.4(c)(iii). (ii) The Company agrees represents that (i) it has treated and or agrees that it will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433 under the Securities Act, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at any time following recordkeeping. (iii) The Company consents to the issuance use (including the making of an Issuer Free Writing Prospectus there occurs an event or development as a result statements) by the Agents of which such Issuer Free Writing Prospectus would conflict (A) information with respect to the terms of the applicable Notes in communications conveying information contained in the Registration Statement relating to the Offered applicable offering of Notes to investors prior to the preparation of the Approved Term Sheet, (B) information consistent with information that would be contained in a notice under Rule 134 under the Securities or would include an untrue statement Act and not inconsistent with information specifically set forth in the Time of material fact or would omit to state a material fact necessary in order to make the statements thereinSale Information, in light of each case which would not be required to be filed by the circumstances prevailing at that subsequent time, not misleading, Agents or the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act, (C) information that describes the final terms of the Notes or their offering and that is consistent with the Approved Term Sheet of the Company and (D) information consistent with information that is in the public domain and is not inconsistent with information specifically set forth in the Time of Sale Information, which in the case of (A) through (D) above would not be required to be filed by the Agents or the Company with the Commission under Rule 433(d) under the Securities Act.

Appears in 2 contracts

Samples: Distribution Agreement (SLM Corp), Distribution Agreement (SLM Corp)

Permitted Free Writing Prospectuses. The Company Each Transaction Party represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeLead Managers, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by any Transaction Party with the Commission or retained by the Company any Transaction Party under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included identified in Schedule Annex I heretoand Annex II to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Each Transaction Party agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Transaction Parties consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an the Securities or their offering or (ii) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Parent Guarantor and the Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict contemplated in Section 3(k) hereof; provided that each Underwriter severally covenants with the information contained Transaction Parties not to take any action without the Transaction Parties’ consent that would result in the Registration Statement relating a free writing prospectus being required to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission under Rule 433(d) under the Securities Act that otherwise would not be required to be filed by any electronic road showTransaction Party thereunder, but for the action of such Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Prologis, L.P.), Underwriting Agreement (Prologis, L.P.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) hereof or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent, which consent shall be confirmed in writing, that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Aes Corp), Underwriting Agreement (Aes Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeUnderwriters, it will not make, any offer relating to the Offered Securities Notes that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, 0000 Xxx) required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and Regulations1933 Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included in Schedule I heretoB to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the 1933 Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Notes or development as a result their offering, (ii) information permitted by Rule 134 under the 1933 Act, or (iii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Notes or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 3(m); provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showpursuant to Rule 433(d) under the 1933 Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (McCormick & Co Inc), Underwriting Agreement (McCormick & Co Inc)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Common Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I C hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company represents and agrees that (iA) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (iiB) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to or the Offered Securities Prospectuses, including, in each case, any document incorporated by reference therein that has not been superseded or would modified. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 2 contracts

Samples: Equity Distribution Agreement (SolarBank Corp), Equity Distribution Agreement (SolarBank Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, in all material respects with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Cit Group Inc), Underwriting Agreement (Cit Group Inc)

Permitted Free Writing Prospectuses. The Company represents Issuers represent that they have not made, and agrees that it has not made andagree that, unless it obtains they obtain the prior written consent of the Representative, they will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Issuers with the Commission or retained by the Company Issuers under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Issuers agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Issuers consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Issuers contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Issuers not to take any action without the Issuers’ consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Issuers being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Issuers thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Regency Energy Partners LP), Underwriting Agreement (Regency Energy Partners LP)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Notes that constitutes or would constitute an “issuer free writing prospectus” as defined in Rule 433 under the Securities Act (each, an “Issuer Free Writing Prospectus”) or that would otherwise constitute a “free writing prospectus” as defined in Rule 405 of under the Rules and Regulations, Securities Act or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included identified in Schedule I C hereto. Any such free writing prospectus consented to to, or deemed consented to, by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at Each Underwriter, severally and not jointly, represents and agrees that, without the prior consent of the Company and the Representative it has not made and will not make any time following offer relating to the issuance Notes that would constitute a free writing prospectus as defined in Rule 405 under the Securities Act, other than a Permitted Free Writing Prospectus or a free writing prospectus that is not required to be filed with the SEC. Notwithstanding anything to the contrary contained herein (including the preceding sentence), the Company consents to the use by the Underwriters of a free writing prospectus that contains only (a) (i) information describing the preliminary terms of the Notes or their offering, (ii) information meeting the requirements of Rule 134 under the Securities Act or (iii) information that describes the final terms of the Notes or their offering and that is or is to be included in the Final Term Sheet or (b) other customary information that is neither “issuer information,” as defined in Rule 433 under the Securities Act, nor otherwise an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectus.

Appears in 2 contracts

Samples: Underwriting Agreement (Old Republic International Corp), Underwriting Agreement (Old Republic International Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeUnderwriters, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Underwriters hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoD hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included on Schedule D hereto contemplated in Section 1(A)(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriters.

Appears in 2 contracts

Samples: Underwriting Agreement (Graphic Packaging Holding Co), Underwriting Agreement (Graphic Packaging Holding Co)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I B hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Yield10 Bioscience, Inc.), Underwriting Agreement (Yield10 Bioscience, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeRepresentatives, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative Representatives is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Gamida Cell Ltd.), Underwriting Agreement (Gamida Cell Ltd.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeRepresentatives, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative Representatives is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 2 contracts

Samples: Underwriting Agreement (Ivanhoe Electric Inc.), Underwriting Agreement (Ivanhoe Electric Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) hereof or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent, which consent shall be confirmed in writing, that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Aes Corp), Underwriting Agreement (Aes Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, in all material respects with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter sev- erally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Cit Group Inc), Underwriting Agreement (Cit Group Inc)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeUnderwriters, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Underwriters hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, in all material respects with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus,” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Cit Group Inc), Underwriting Agreement (Cit Group Inc)

Permitted Free Writing Prospectuses. The Company represents Ventas Entities represent, jointly and agrees severally, that it has they have not made andmade, and agree that, unless it obtains they obtain the prior written consent of the RepresentativeUnderwriter, they will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Underwriter hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoAnnex A hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Underwriter is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Ventas Entities consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result of which such Issuer Free Writing Prospectus would conflict their offering or (ii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Ventas Entities being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that would not be required to be filed by the Ventas Entities thereunder but for the action of the Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Ventas Inc), Underwriting Agreement (Prometheus Senior Quarters LLC)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeBMOCM, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative BMOCM hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative BMOCM is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in BMOCM or the issuance Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer BMOCM that BMOCM otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by BMOCM expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify the Representative give prompt notice thereof to BMOCM and, if requested by BMOCM, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to BMOCM an Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by BMOCM expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Gold Standard Ventures Corp.), Equity Distribution Agreement (Gold Standard Ventures Corp.)

Permitted Free Writing Prospectuses. The Company Each Transaction Party represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeLead Managers, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by any Transaction Party with the Commission or retained by the Company any Transaction Party under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included identified in Schedule Annex I heretoand Axxxx XX to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Each Transaction Party agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Transaction Parties consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an the Securities or their offering or (ii) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Parent Guarantor and the Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict contemplated in Section 3(k) hereof; provided that each Underwriter severally covenants with the information contained Transaction Parties not to take any action without the Transaction Parties’ consent that would result in the Registration Statement relating a free writing prospectus being required to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission under Rule 433(d) under the Securities Act that otherwise would not be required to be filed by any electronic road showTransaction Party thereunder, but for the action of such Underwriter.

Appears in 2 contracts

Samples: Underwriting Agreement (Prologis, Inc.), Underwriting Agreement (Prologis, L.P.)

Permitted Free Writing Prospectuses. The Company represents represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, 405) or portion thereof required to be filed with the Commission or required to be retained by the Company under pursuant to Rule 433 of the Rules and Regulations433; provided that the prior written consent of the Representative hereto Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit H hereto, to any electronic road show in Schedule the form previously provided by the Company to and approved by the Representatives, and to any Issuer RSP Free Writing Prospectus listed on Exhibit I hereto. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents, warrants and agrees that (i) it has treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at , and the only information included in any time following the issuance of an Issuer RSP Free Writing Prospectus there occurs an event is the same information that is set forth in Exhibit G hereto. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit H or development as a result of which such Issuer Exhibit I hereto are Permitted Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 2 contracts

Samples: Underwriting Agreement (Angel Oak Mortgage, Inc.), Underwriting Agreement (Angel Oak Mortgage, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has shall not made and, unless it obtains the prior consent of the Representative, will not make, make any offer relating to the Offered Securities Shares that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 under the Securities Act without the prior written consent of the Rules Representatives, the Forward Seller and Regulationsthe Forward Purchaser; provided that the prior written consent of the Representative hereto Representatives, the Forward Seller and the Forward Purchaser shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included identified in Schedule I heretoAnnex A hereto and any electronic road show. Any such Issuer Free Writing Prospectus or other free writing prospectus consented to by the Representative Representatives, the Forward Seller and the Forward Purchaser is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, Prospectus and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If The Company consents to the use by any Underwriter, Forward Seller or Forward Purchaser of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the preliminary terms of the Shares or their offering, (or (ii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter, Forward Seller or Forward Purchaser severally covenants with the Company not to take any action without the Company’s consent (which consent shall be confirmed in writing) that would result in the Company being required to file with the Commission under Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter, Forward Seller or Forward Purchaser that would not be required to be filed by the Company thereunder but for the action of the Underwriter. If, at any time following the issuance of an Issuer Free Writing Prospectus there occurs an Prospectus, any event or development shall occur as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities that has not been superseded or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleadingmodified, the Company will agrees to promptly notify the Representative Representatives, the Forward Seller and will the Forward Purchaser of such event and promptly amend or supplement, at its own expense, supplement such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 1 contract

Samples: Underwriting Agreement (Ventas, Inc.)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeBMOCM, will shall not make, any offer relating to the Offered Securities Shares that would constitute a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative BMOCM hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative BMOCM is herein referred to as a "Permitted Free Writing Prospectus." The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in BMOCM or the issuance Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer BMOCM that BMOCM otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectus. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by BMOCM expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectus or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify the Representative give prompt notice thereof to BMOCM and, if requested by BMOCM, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to BMOCM an Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by BMOCM expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 1 contract

Samples: Equity Distribution Agreement (First Majestic Silver Corp)

AutoNDA by SimpleDocs

Permitted Free Writing Prospectuses. The Company represents Ventas Entities represent, jointly and agrees severally, that it has they have not made andmade, and agree that, unless it obtains they obtain the prior written consent of the RepresentativeRepresentatives, they will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoD hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Ventas Entities consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Notes or development as a result their offering, (ii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Notes or their offering and that is included in the Final Term Sheet of the Ventas Entities contemplated in Section 1(iv) hereof, or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Ventas Entities being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Ventas Entities thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Ventas Inc)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities Units that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Units or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 1 contract

Samples: Underwriting Agreement (Ivanhoe Electric Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I C hereto. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that it (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, or other information included in the Disclosure Package, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Celanese Corp)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeBMOCM, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative BMOCM hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative BMOCM is herein referred to as a “Permitted Free Writing Prospectus.” The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to BMOCM and, if requested by BMOCM, will prepare and furnish without charge to the Representative and will promptly amend or supplement, at its own expense, such Issuer Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 1 contract

Samples: Equity Distribution Agreement (Ballard Power Systems Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 4(d) hereof or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Davita Inc)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following the issuance Underwriter of a free writing prospectus that (a) is not an Issuer Free Writing Prospectus there occurs an event or development “issuer free writing prospectus” as defined in Rule 433, (b) would not, solely as a result of which use by such Issuer Free Writing Prospectus would conflict Underwriter, trigger an obligation to file such free writing prospectus with the information contained Commission pursuant to Rule 433, (c) is listed on Schedule C of this Agreement, including the Final Term Sheet and any electronic road show, (d) is prepared pursuant to Section 1(f) of this Agreement, or (e) is prepared by such Underwriter and approved by the Company in advance in writing; provided that each Underwriter severally covenants with the Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Briggs & Stratton Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeUnderwriter, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Underwriter hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I A hereto. Any such free writing prospectus consented to by the Representative Underwriter is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Underwriter and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 1 contract

Samples: Underwriting Agreement (Apollo Endosurgery, Inc.)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided, however, the foregoing shall not apply to any statements in or omissions from any Permitted Free Writing Prospectus made in reliance on and in conformity with information relating to the Agents furnished in writing to the Company by or on behalf of the Agents expressly for inclusion therein, it being understood and agreed that the only such information is as described in Section 5(b) hereof. (iii) The Company agrees that if at any time following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements in or omissions from any Permitted Free Writing Prospectus made in reliance on and in conformity with information relating to the Agents furnished in writing to the Company represents by or on behalf of the Agents expressly for inclusion therein, it being understood and agreed that it has satisfied and agrees that it will satisfy the conditions only such information is as described in Rule 433 to avoid a requirement to file with the Commission any electronic road showSection 5(b) hereof.

Appears in 1 contract

Samples: Equity Distribution Agreement (GoldMining Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included identified in Schedule I C hereto. Any such free writing prospectus consented to to, or deemed consented to, by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at Each Underwriter, severally and not jointly, represents and agrees that, without the prior consent of the Company and the Representative it has not made and will not make any time following offer relating to the issuance Securities that would constitute a free writing prospectus as defined in Rule 405 under the Securities Act, other than a Permitted Free Writing Prospectus or a free writing prospectus that is not required to be filed with the SEC. Notwithstanding anything to the contrary contained herein (including the preceding sentence), the Company consents to the use by the Underwriters of a free writing prospectus that contains only (a) (i) information describing the preliminary terms of the Securities or their offering, (ii) information meeting the requirements of Rule 134 under the Securities Act or (iii) information that describes the final terms of the Securities or their offering and that is or is to be included in the Final Term Sheet or (b) other customary information that is neither “issuer information,” as defined in Rule 433 under the Securities Act, nor otherwise an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectus.

Appears in 1 contract

Samples: Underwriting Agreement (Old Republic International Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Public Securities that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I II hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Public Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 1 contract

Samples: Underwriting Agreement (La Rosa Holdings Corp.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I C hereto. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that it (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering or other information included in the Disclosure Package, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Celanese Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Representative, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I B hereto. Any such free writing prospectus consented to by the Representative is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act Rules and Regulations applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 1 contract

Samples: Underwriting Agreement (Agroz Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating The Company consents to the Offered Securities or would include use by any Underwriter of a free writing prospectus that (a) is not an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions “issuer free writing prospectus” as defined in Rule 433 that would be required to avoid a requirement be filed by the Company with the Commission, or (b) contains only (1) information describing the preliminary terms of the Securities or their offering, (2) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d)(iv) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Company being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Bill Barrett Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall not be unreasonably withheld and will be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB-1 hereto and any electronic road show including the investor presentation listed on Schedule B-2 hereto (the “investor presentation”). Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating The Company consents to the Offered Securities or would include use by any Underwriter of a free writing prospectus that (a) is not an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions “issuer free writing prospectus” as defined in Rule 433 under the Securities Act, or (b) contains only (1) information describing the preliminary terms of the Securities or their offering, (2) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 3(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Company not to avoid a requirement take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Company being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Spirit AeroSystems Holdings, Inc.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that it (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, or other information included in the Disclosure Package, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Celanese Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules Securities Act); each Underwriter represents that it has not made, and Regulationsagrees that, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that unless it obtains the prior written consent of the Representative hereto shall be deemed Company and the Representative, it will not make, any offer relating to have been given the Notes that would constitute an “issuer free writing prospectus” as defined in respect of the Rule 433 (an “Issuer Free Writing Prospectuses included in Schedule I heretoProspectus”). Any such free writing prospectus consented to by the Representative and the Company is herein hereinafter referred to as a “Permitted Free Writing Prospectus.and is included in Schedule B to this Agreement. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following the issuance Underwriter of a free writing prospectus that (a) is not an Issuer Free Writing Prospectus there occurs an event Prospectus, and (b) contains only (i) information describing the preliminary terms of the Notes or development as a result their offering or (ii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Notes or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 3(i); provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Pmi Group Inc)

Permitted Free Writing Prospectuses. The Company represents represents, warrants and agrees that it has not made andthat, unless it obtains the prior written consent of JMP, and JMP represents, warrants and agrees that, unless it obtains the prior written consent of the RepresentativeCompany, it has not made and will not make, make any offer relating to the Offered Securities Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 of the Rules and Regulations405, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoCommission. Any such free writing prospectus consented to by JMP or by the Representative Company, as the case may be, is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” ”. The Company agrees represents and warrants that (i) it has treated and agrees that it will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at any time following For the issuance purposes of an Issuer clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit G hereto are Permitted Free Writing Prospectus there occurs an event or development as Prospectuses. If the foregoing correctly sets forth the understanding between the Company and JMP, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a result of which such Issuer Free Writing Prospectus would conflict with binding agreement between the information Company and JMP. Very truly yours, By: /s/ Xxxxxxx X. Xxxxxxxxx Name: Xxxxxxx X. Xxxxxxxxx Title: Executive Vice President, Chief Operating Officer and Chief Financial Officer By: /s/ Xxxx Xxxxxxx Name: Xxxx Xxxxxxx Title: Managing Director From: [ ] Cc: [ ] To: [ ] Subject: Equity Distribution Offering—Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Registration Statement relating to Amended and Restated Equity Distribution Agreement between Dynex Capital, Inc., (the Offered “Company”) and JMP Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make LLC (“JMP”) dated March 31, 2017 (the statements therein“Agreement”), in light I hereby request on behalf of the circumstances prevailing Company that JMP sell up to [ ] shares (the “Placement Shares”) of the Company’s common stock, par value $0.01 per share, at a minimum market price of $[ ] per Placement Share between [ ], 20[ ] and [ ], 20[ ]. [There shall be no limitation on the number of Placement Shares that subsequent timemay be sold on any one (1) day.] [No more than [ ] Placement Shares may be sold on any one (1) day.] ADDITIONAL SALES PARAMETERS MAY BE ADDED, not misleadingSUCH AS THE SPECIFIC DATES THE SHARES MAY NOT BE SOLD ON, THE MANNER IN WHICH SALES ARE TO BE MADE BY JMP, AND/OR THE CAPACITY IN WHICH JMP MAY ACT IN SELLING SHARES (AS PRINCIPAL, AGENT OR BOTH). Very truly yours, By: Name: [ ] Title: [ ] The amount of any discount, commission or other compensation to be paid by the Company will promptly notify to JMP shall be up to two percent (2.0%) of the Representative gross proceeds with respect to sales of the Placement Shares actually effected by JMP. Xxxx Xxxxxxx xxxxxxxx@xxxxxxxxxxxxx.xxx Xxxxxx Xxxxxxxx xxxxxxxxx@xxxxxxxxxxxxx.xxx Xxxxxx Xxxxxx xxxxxxx@xxxxxxxxxxxxx.xxx Xxx Xxxxxxxx xxxxxxxxx@xxxxxxxxxxxxx.xxx Xxxxx Boston (Chief Executive Officer, President and will promptly amend or supplementCo-Chief Investment Officer) Xxxxx Xxxxxxxxx (Executive Vice President, at its own expenseChief Operating Officer and Chief Financial Officer) Xxxx Childress (Vice President and Controller) Mortgage Investment Corporation MSC I L.P. Investment Capital Access, Inc.* Commercial Capital Access One, Inc.* MERIT Securities Corporation* Financial Asset Securitization, Inc.* Issued Holdings Capital Corporation* GLS Capital, Inc. GLS Properties, LLC Allegheny Commercial Properties I, LLC Allegheny Income Properties I, LLC Allegheny Special Properties, LLC Dynex Commercial Services, Inc. Dynex Securities Corporation SMFC Funding Corporation SHF Corp. St. Xxxx Acquisition Limited Partnership * Denotes a “significant subsidiary”, as such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions term is defined in Rule 433 to avoid a requirement to file with 1-02 of Regulation S-X promulgated under the Commission any electronic road showExchange Act.

Appears in 1 contract

Samples: Equity Distribution Agreement (Dynex Capital Inc)

Permitted Free Writing Prospectuses. The Company Each Transaction Party represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeLead Managers, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by any Transaction Party with the Commission or retained by the Company any Transaction Party under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included identified in Schedule Annex I heretoand Xxxxx XX to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Each Transaction Party agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Transaction Parties consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an the Securities or their offering or (ii) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Parent Guarantor and the Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict contemplated in Section 3(k) hereof; provided that each Underwriter severally covenants with the information contained Transaction Parties not to take any action without the Transaction Parties’ consent that would result in the Registration Statement relating a free writing prospectus being required to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission under Rule 433(d) under the Securities Act that otherwise would not be required to be filed by any electronic road showTransaction Party thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Prologis, L.P.)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior consent written consents of the RepresentativeAgents, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent consents of the Representative Agents hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 2 hereto. Any such free writing prospectus consented to by the Representative Agents is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agents or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agents that the Agents otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agents expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agents and, if requested by the Agents, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agents a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agents expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 1 contract

Samples: Equity Distribution Agreement (New Found Gold Corp.)

Permitted Free Writing Prospectuses. The Company Each Transaction Party represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeLead Managers, it will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) required to be filed by any Transaction Party with the Commission or retained by the Company any Transaction Party under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto Underwriters shall be deemed to have been given in respect of the any Issuer Free Writing Prospectuses included identified in Schedule Annex I heretoand Annex II to this Agreement. Any such free writing prospectus consented to or deemed to be consented to by the Representative Underwriters is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Each Transaction Party agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Transaction Parties consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an the Securities or their offering or (ii) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Parent Guarantor and the Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict contemplated in Section 3(k); provided that each Underwriter severally covenants with the information contained Transaction Parties not to take any action without the Transaction Parties’ consent that would result in the Registration Statement relating a free writing prospectus being required to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file be filed with the Commission under Rule 433(d) under the Securities Act that otherwise would not be required to be filed by any electronic road showTransaction Party thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Prologis, L.P.)

Permitted Free Writing Prospectuses. The Company represents and each of the Selling Stockholders, severally and not jointly, represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, and each Underwriter, severally and not jointly, represents, warrants and agrees that it had not made and, unless it obtains the prior written consent of the Company and the Representatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433 under the 0000 Xxx) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and Regulations, 0000 Xxx) or portion thereof required to be filed with the Commission or required to be retained by the Company under pursuant to Rule 433 of under the Rules and Regulations1933 Act; provided that the prior written consent of the Representative hereto Company and the Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit I hereto, to any electronic road show in Schedule I the form previously provided by the Company to and approved by the Representatives, and to any Issuer RSP Free Writing Prospectus listed on Exhibit J hereto. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents, warrants and agrees that (i) it has treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433 under the 1933 Act, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of under the 1933 Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at , and the only information included in any time following the issuance of an Issuer RSP Free Writing Prospectus there occurs an event is the same information that is set forth in Exhibit J hereto. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit I or development as a result of which such Issuer Exhibit J hereto are Permitted Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 1 contract

Samples: Underwriting Agreement (Guild Holdings Co)

Permitted Free Writing Prospectuses. (a) The Company represents and agrees that it has not made andthat, unless it obtains without the prior consent of the RepresentativeUnderwriters, it has not made and will not make, make any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of under the Rules and Regulations, Securities Act required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any Securities Act, other than any such free writing prospectus the use of which has been consented to by the Representative Company and the Underwriters as is herein referred listed on Schedule C hereto; each Selling Stockholder represents and agrees that, without the prior consent of the Company and the Underwriters, it has not made and will not make any offer relating to the Shares that would constitute a free writing prospectus; and each Underwriter represents and agrees that, without the prior consent of the Company and the other Underwriters, it has not made and will not make any offer relating to the Shares that would constitute a free writing prospectus required to be filed with the Commission, other than any such free writing prospectus the use of which has been consented to by the Company and the Underwriters as a “Permitted Free Writing Prospectus.” is listed on Schedule C hereto; (b) The Company agrees that (i) it has treated complied and will treat, as comply with the case may be, each Permitted Free Writing Prospectus as an requirements of Rule 433 under the Securities Act applicable to any Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission or retention where required and legending. (c) The Company agrees that, legending and record keeping. If during the Prospectus Delivery Period, if at any time following the issuance of an Issuer Free Writing Prospectus there any event occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to Statement, the Offered Securities Preliminary Prospectus or the Prospectus or would include an untrue statement of a material fact or would omit to state a any material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that subsequent timethen prevailing, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Underwriters and, if requested by the Underwriters, will prepare and furnish without charge to each Underwriter an Issuer Free Writing Prospectus, or other document which will promptly amend correct such statement or supplementomission; provided, at its own expensehowever, such that this obligation shall not apply to any statements or omissions in an Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied made in reliance upon and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file conformity with the Commission any electronic road showUnderwriter Information or the Selling Stockholder Information.

Appears in 1 contract

Samples: Underwriting Agreement (Td Ameritrade Holding Corp)

Permitted Free Writing Prospectuses. The Company represents Ventas Entities represent, jointly and agrees severally, that it has they have not made andmade, and agree that, unless it obtains they obtain the prior written consent of the RepresentativeRepresentatives, they will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Ventas Entities consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Notes or development as a result their offering, (ii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Notes or their offering and that is included in the Final Term Sheet of the Ventas Entities contemplated in Section 1(iv) hereof, or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Ventas Entities being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that would not be required to be filed by the Ventas Entities thereunder but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Ventas Inc)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” as defined in Rule 433 under the Securities Act (each, an “Issuer Free Writing Prospectus”) or that would otherwise constitute a “free writing prospectus” as defined in Rule 405 of under the Rules and Regulations, Securities Act or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of under the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included identified in Schedule I C hereto. Any such free writing prospectus consented to to, or deemed consented to, by the Representative Representatives is herein referred to as a “Permitted Free Writing Prospectus.” ”. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of under the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at Each Underwriter, severally and not jointly, represents and agrees that, without the prior consent of the Company and the Representatives it has not made and will not make any time following offer relating to the issuance Securities that would constitute a free writing prospectus as defined in Rule 405 under the Securities Act, other than a Permitted Free Writing Prospectus or a free writing prospectus that is not required to be filed with the SEC. Notwithstanding anything to the contrary contained herein (including the preceding sentence), the Company consents to the use by the Underwriters of a free writing prospectus that contains only (a) (i) information describing the preliminary terms of the Securities or their offering, (ii) information meeting the requirements of Rule 134 under the Securities Act or (iii) information that describes the final terms of the Securities or their offering and that is or is to be included in the Final Term Sheet or (b) other customary information that is neither “issuer information,” as defined in Rule 433 under the Securities Act, nor otherwise an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectus.

Appears in 1 contract

Samples: Underwriting Agreement (Old Republic International Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, including without limitation for the purposes of this Agreement, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Activision Blizzard, Inc.)

Permitted Free Writing Prospectuses. The Unless the Company represents has notified or notifies the Agents, the Forward Sellers and agrees that it has not made andthe Forward Purchasers otherwise in accordance with Section 4(f) hereof, unless it obtains no “issuer free writing prospectus” (as defined in Rule 433 under the prior consent of the Representative, will not make, any offer relating to the Offered Securities Act) or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405 of under the Rules and RegulationsAct) conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, required including any document incorporated or deemed incorporated by reference therein, or any preliminary or other prospectus deemed to be filed with the Commission a part thereof that has not been superseded or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretomodified. Any such free writing prospectus relating to the Shares consented to by the Representative applicable Agents, the applicable Forward Sellers and the applicable Forward Purchasers (including any Free Writing Prospectus prepared by the Company solely for use in connection with the offering contemplated by a particular Terms Agreement) is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each ”. Each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with conformed in all material respects to the requirements of Rules 164 the Act on the date of first use, and the Company has complied with any filing requirements applicable to a Permitted Free Writing Prospectus pursuant to the Act. The Company has not made any offer relating to the Shares or that would constitute an “issuer free writing prospectus” as defined under Rule 433 of the Act without the prior written consent of the applicable Agents, the applicable Forward Sellers and the applicable Forward Purchasers. The Company has retained in accordance with the Act all issuer free writing prospectuses that were not required to be filed pursuant to the Act. The first sentence of this Section 3(c) shall not apply to statements in or omissions from any Permitted Free Writing Prospectus, including Prospectus in respect of timely filing reliance upon and in conformity with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the written information contained in the Registration Statement relating furnished to the Offered Securities Company by any Agent, Forward Seller or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements Forward Purchaser specifically for use therein, in light it being understood and agreed that the only such information furnished by any Agent, Forward Seller or Forward Purchaser consists of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showAgent Information.

Appears in 1 contract

Samples: Distribution Agreement (Plymouth Industrial REIT, Inc.)

Permitted Free Writing Prospectuses. The Company represents that neither it nor anyone acting on its behalf has made, and agrees that it has not made andthat, unless it obtains the prior written consent of the Representative, neither it nor anyone acting on its behalf will not make, any offer relating to the Offered Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a free writing prospectus” as defined in Rule 405 of the Rules and Regulations, prospectus required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and Regulations433; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included each free writing prospectus (as defined in Rule 405), if any, that is attached hereto as Schedule I hereto. C. Any such free writing prospectus that is consented to, or is deemed to have been consented to, by the Representative is herein referred to herein as a “Permitted Free Writing Prospectus.” ”. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the 1933 Act Regulations applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Underwriters agree that, unless they obtain the prior written consent of the Company and, in the case of the Underwriters other than the Representative, the Representative, they will not make any time following offer relating to the issuance Securities that constitutes or would constitute a free writing prospectus required to be filed with the Commission under Rule 433. Notwithstanding the foregoing, the Company consents to the use by any Underwriter of a free writing prospectus that (a) is not an Issuer Free Writing Prospectus there occurs an event or development as a result Prospectus, and (b) contains only (i) information describing the preliminary terms of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact their offering, (ii) information permitted by Rule 134 or would omit to state a material fact necessary in order to make (iii) information that describes the statements therein, in light final terms of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Securities or their offering and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showother customary information relating thereto.

Appears in 1 contract

Samples: Purchase Agreement (Vectren Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I C hereto. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that it (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, or other information included in the Disclosure Package, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Celanese Corp)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeBMOCM, will shall not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative BMOCM hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative BMOCM is herein referred to as a “Permitted Free Writing Prospectus.” The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in BMOCM or the issuance Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer BMOCM that BMOCM otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectus. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by BMOCM expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectus or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify the Representative give prompt notice thereof to BMOCM and, if requested by BMOCM, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to BMOCM an Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by BMOCM expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 1 contract

Samples: Equity Distribution Agreement (First Majestic Silver Corp)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made and, unless it obtains the prior consent of the RepresentativeCo-Representatives, will not make, any offer relating to the Offered Securities Shares that would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and Regulations, required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Co-Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I hereto. Any such free writing prospectus consented to by the Representative Co-Representatives is herein referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities Shares or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative Co-Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

Appears in 1 contract

Samples: Underwriting Agreement (Apollo Endosurgery, Inc.)

Permitted Free Writing Prospectuses. The Company represents Ventas Entities represent, jointly and agrees severally, that it has they have not made andmade, and agree that, unless it obtains they obtain the prior written consent of the RepresentativeUnderwriter, they will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoSecurities Act. Any such free writing prospectus consented to by the Representative Underwriter is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Ventas Entities consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result of which such Issuer Free Writing Prospectus would conflict their offering or (ii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Ventas Entities being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that would not be required to be filed by the Ventas Entities thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Ventas Inc)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will complycomply in all material respects, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating The Company consents to the Offered Securities or would include use by any Underwriter of (i) the Final Term Sheet and (ii) a free writing prospectus that (a) is not an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions “issuer free writing prospectus” as defined in Rule 433 and (b) contains only (1) information describing the preliminary terms of the Securities or their offering, (2) information that describes the final terms of the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 5(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the Company not to avoid a requirement take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Company being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Catamaran Corp)

Permitted Free Writing Prospectuses. (i) The Company represents and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeAgent, will shall not make, any offer relating to the Offered Securities Shares that would constitute a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations, which is required to be filed with the Commission or retained by the Company under Rule 433 of the Rules and Regulations; provided that the prior written consent of the Representative Agent hereto shall be deemed to have been given in respect of each of the Issuer Free Writing Prospectuses included free writing prospectuses set forth in Schedule I 3 hereto. Any such free writing prospectus consented to by the Representative Agent is herein referred to as a "Permitted Free Writing Prospectus." The Company represents and agrees that (i) it has treated and will shall treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, a "free writing prospectus" as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and will shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including including, without limitation, in respect of timely filing with the Commission, legending and record keeping. If at The Company agrees not to take any time following action that would result in the issuance Agent or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of an Issuer the Agent that the Agent otherwise would not have been required to file thereunder. (ii) The Company agrees that no Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict Prospectus, if any, will include any information that conflicts with the information contained in the Registration Statement relating to Statement, including any document incorporated by reference therein that has not been superseded or modified, or the Offered Securities or would Prospectuses. In addition, no Permitted Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing under which they were made, not misleading; provided however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company by the Agent expressly stating that such information is intended for use therein. (iii) The Company agrees that if at any time following issuance of an Permitted Free Writing Prospectus any event occurred or occurs as a result of which such Permitted Free Writing Prospectus would conflict with the information in the Registration Statement, including any document incorporated by reference therein that subsequent timehas not been superseded or modified, or the Prospectuses or would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company will promptly notify give prompt notice thereof to the Representative Agent and, if requested by the Agent, will prepare and will promptly amend or supplement, at its own expense, such Issuer furnish without charge to the Agent a Permitted Free Writing Prospectus to eliminate or other document which will correct such conflict, untrue statement, statement or omission. The ; provided, however, the foregoing shall not apply to any statements or omissions in any Permitted Free Writing Prospectus made in reliance on information furnished in writing to the Company represents by the Agent expressly stating that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showsuch information is intended for use therein.

Appears in 1 contract

Samples: Equity Distribution Agreement (Integra Resources Corp.)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the Representative, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoD hereto and any electronic road show. Any such free writing prospectus consented to by the Representative is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” ”. The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 1(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Cardtronics Inc)

Permitted Free Writing Prospectuses. The Company represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, Prospectus and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Company consents to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Company contemplated in Section 4(d) hereof, (3) information describing the Company that is included in the Disclosure Package or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Company not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of such Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Davita Healthcare Partners Inc.)

Permitted Free Writing Prospectuses. The Company represents represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, and each Underwriter, severally and not jointly, represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the Company and the Representatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, 405) or portion thereof required to be filed with the Commission or required to be retained by the Company under pursuant to Rule 433 of the Rules and Regulations433; provided that the prior written consent of the Representative hereto Company and the Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit H hereto and to any electronic road show in Schedule the form previously provided by the Company to and approved by the Representatives, and to any Issuer DSP Free Writing Prospectus listed on Exhibit I hereto. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents, warrants and agrees that (i) it has treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at , and the only information included in any time following the issuance of an Issuer DSP Free Writing Prospectus there occurs an event is the same information that is set forth in Exhibit G hereto. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit H or development as a result of which such Issuer I hereto are Permitted Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 1 contract

Samples: Underwriting Agreement (Tabula Rasa HealthCare, Inc.)

Permitted Free Writing Prospectuses. The Company Each of the Issuers represents and agrees that it has not made andmade, and agrees that, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Company with the Commission or retained by the Company Issuers under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included in Schedule I heretoC hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company Each of the Issuers agrees that (i) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Issuers consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, or (b) contains only (1) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Securities or development as a result their offering, (2) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Securities or their offering and that is included in the Final Term Sheet of the Issuers contemplated in Section 4(d) or (3) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Issuers not to take any action without the Company’s consent which consent shall be confirmed in writing that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Issuers being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Issuers thereunder, but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Kraton Performance Polymers, Inc.)

Permitted Free Writing Prospectuses. The Company represents Ventas Entities represent, jointly and agrees severally, that it has they have not made andmade, and agree that, unless it obtains they obtain the prior written consent of the RepresentativeRepresentatives, they will not make, any offer relating to the Offered Securities Notes that constitutes or would constitute an Issuer Free Writing Prospectus or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, Securities Act) or a portion thereof required to be filed by the Ventas Entities with the Commission or retained by the Company Ventas Entities under Rule 433 of the Rules and RegulationsSecurities Act; provided that the prior written consent of the Representative Representatives hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectuses included described in Schedule I heretoB hereto and any electronic road show. Any such free writing prospectus consented to by the Representative Representatives is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees Ventas Entities agree that (i) it has they have treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has they have complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. If at The Ventas Entities consent to the use by any time following Underwriter of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains only (i) information describing the issuance preliminary terms of an Issuer Free Writing Prospectus there occurs an event the Notes or development as a result their offering, (ii) information that describes the final terms of which such Issuer Free Writing Prospectus would conflict the Notes or their offering and that is included in the Final Term Sheet of the Ventas Entities contemplated in Section 1(iv) hereof, or (iii) information permitted under Rule 134 under the Securities Act; provided that each Underwriter severally covenants with the information contained Ventas Entities not to take any action without the Ventas Entities’ consent (which consent shall be confirmed in writing) that would result in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement Ventas Entities being required to file with the Commission any electronic road showunder Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that would not be required to be filed by the Ventas Entities thereunder but for the action of the Underwriter.

Appears in 1 contract

Samples: Underwriting Agreement (Ventas Inc)

Permitted Free Writing Prospectuses. The Company represents represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the RepresentativeRepresentatives, it will not make, and each Underwriter, severally and not jointly, represents, warrants and agrees that it has not made and, unless it obtains the prior written consent of the Company and the Representatives, it will not make, any offer relating to the Offered Securities that constitutes or would constitute an “issuer free writing prospectus” (as defined in Rule 433) or that otherwise constitutes or would constitute a “free writing prospectus” (as defined in Rule 405 of the Rules and Regulations, 405) or portion thereof required to be filed with the Commission or required to be retained by the Company under pursuant to Rule 433 of the Rules and Regulations433; provided that the prior written consent of the Representative hereto Company and the Representatives shall be deemed to have been given in respect of the Issuer General Use Free Writing Prospectuses included Prospectuses, if any, listed on Exhibit I hereto and to any electronic road show in Schedule I heretothe form previously provided by the Company to and approved by the Representatives. Any such free writing prospectus consented to by the Representative or deemed to have been consented to as aforesaid is herein hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents, warrants and agrees that (i) it has treated and will treat, as the case may be, treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus“issuer free writing prospectus,” as defined in Rule 433, and (ii) has complied and will comply, as the case may be, comply with the requirements of Rules 164 and Rule 433 of the Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the CommissionCommission where required, legending and record keeping. If at any time following For the issuance purposes of an Issuer clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit I hereto are Permitted Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement relating to the Offered Securities or would include an untrue statement of material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement, or omission. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road showProspectuses.

Appears in 1 contract

Samples: Underwriting Agreement (Insys Therapeutics, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!